Market Overview

UPDATE: Morgan Stanley Raises PT on Lorillard Following CAGNY Conference

Related LO
Reynolds American's Disappointing Quarter Belies A Strong Growth Story
Weed This Week: Marijuana Usage Has Nearly Doubled Since 2013

In a report published Wednesday, Morgan Stanley analyst Pamela Kaufman increased the price target and remained Neutral on Lorillard (NYSE: LO) from $34 to $45. Kaufman believed this to be a result of Lorillard's strong fundamentals in spite of a competitive industry and lower than expected sales.

In the report, Morgan Stanley noted "In the context of a challenging consumer staples operating environment – e.g., a slowdown in many Emerging Markets, significant FX pressure due to USD strength, a strapped low-end US consumer, selectively reduced consumer responsiveness to promotional spend, low workforce participation & lower government SNAP expenditures – LO's core fundamentals remain strong and resilient. This is a reflection of Newport's solid core franchise, attractive long-term demographics, strong pricing, a relatively stable overall competitive environment, and strong and consistent execution."

On Tuesday, Lorillard closed at $47.31.

Latest Ratings for LO

Oct 2014Cowen & Co.UpgradesUnderperformMarket Perform
Aug 2014Morgan StanleyUpgradesUnderweightEqual-Weight
Jul 2014NomuraUpgradesReduceNeutral

View More Analyst Ratings for LO
View the Latest Analyst Ratings

Posted-In: lorillard Morgan Stanley Pamela KaufmanAnalyst Color Price Target Reiteration Analyst Ratings


Related Articles (LO)

View Comments and Join the Discussion!